TY - JOUR
T1 - Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine
AU - Ferrer-Miralles, Neus
AU - Corchero, José L.
AU - Kumar, Pradeep
AU - Cedano, Juan A.
AU - Gupta, Kailash C.
AU - Villaverde, Antonio
AU - Vazquez, Esther
PY - 2011/12/2
Y1 - 2011/12/2
N2 - Histidine-rich peptides are commonly used in recombinant protein production as purification tags, allowing the one-step affinity separation of the His-tagged proteins from the extracellular media or cell extracts. Genetic engineering makes feasible the post-purification His-tag removal by inserting, between the tag and the main protein body, a target site for trans-acting proteases or a self-proteolytic peptide with regulatable activities. However, for technical ease, His tags are often not removed and the fusion proteins eventually used in this form. In this commentary, we revise the powerful biological properties of histidine-rich peptides as endosomolytic agents and as architectonic tags in nanoparticle formation, for which they are exploited in drug delivery and other nanomedical applications. These activities, generally unknown to biotechnologists, can unwillingly modulate the functionality and biotechnological performance of recombinant proteins in which they remain trivially attached.
AB - Histidine-rich peptides are commonly used in recombinant protein production as purification tags, allowing the one-step affinity separation of the His-tagged proteins from the extracellular media or cell extracts. Genetic engineering makes feasible the post-purification His-tag removal by inserting, between the tag and the main protein body, a target site for trans-acting proteases or a self-proteolytic peptide with regulatable activities. However, for technical ease, His tags are often not removed and the fusion proteins eventually used in this form. In this commentary, we revise the powerful biological properties of histidine-rich peptides as endosomolytic agents and as architectonic tags in nanoparticle formation, for which they are exploited in drug delivery and other nanomedical applications. These activities, generally unknown to biotechnologists, can unwillingly modulate the functionality and biotechnological performance of recombinant proteins in which they remain trivially attached.
UR - http://www.scopus.com/inward/record.url?scp=82455171791&partnerID=8YFLogxK
U2 - https://doi.org/10.1186/1475-2859-10-101
DO - https://doi.org/10.1186/1475-2859-10-101
M3 - Artículo de revisión
C2 - 22136342
AN - SCOPUS:82455171791
VL - 10
M1 - 101
ER -